Wedbush has increased its price target for Xometry to $140 from $126, maintaining an Outperform rating. This adjustment is a direct result of Xometry's strong Q3 2026 earnings, including growth in non-GAAP earnings and revenue, and an upward revision of its 2026 fiscal year revenue outlook.
Wedbush analysts raised their price target on Xometry (XMTR) to $140 from $126, while reiterating an Outperform rating. This positive revision stems from Xometry's robust third-quarter 2026 earnings report, which showcased growth in non-GAAP earnings and revenue, alongside an elevated revenue outlook for the full 2026 fiscal year. This news is a positive catalyst for Xometry, indicating analyst confidence in its financial performance and future growth trajectory. For traders, this suggests potential upward momentum for XMTR stock in the short to medium term, driven by improved sentiment and a higher valuation target from a reputable firm. The key opportunity lies in the potential for the stock price to converge with the new, higher price target, while a risk could be if the company fails to meet its raised revenue outlook in subsequent quarters.